SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-003233
Filing Date
2019-03-13
Accepted
2019-03-13 07:31:31
Documents
52
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 480844
2 ex31-1.htm EX-31.1 20120
3 ex31-2.htm EX-31.2 20215
4 ex32-1.htm EX-32.1 7556
5 ex32-2.htm EX-32.2 7865
  Complete submission text file 0001493152-19-003233.txt   2999006

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE avdx-20181231.xml EX-101.INS 443291
7 XBRL SCHEMA FILE avdx-20181231.xsd EX-101.SCH 48925
8 XBRL CALCULATION FILE avdx-20181231_cal.xml EX-101.CAL 49626
9 XBRL DEFINITION FILE avdx-20181231_def.xml EX-101.DEF 154866
10 XBRL LABEL FILE avdx-20181231_lab.xml EX-101.LAB 294607
11 XBRL PRESENTATION FILE avdx-20181231_pre.xml EX-101.PRE 209068
Mailing Address 1050 30TH STREET NW SUITE 107 WASHINGTON DC 20007
Business Address 1050 30TH STREET NW SUITE 107 WASHINGTON DC 20007 (732) 410-9810
Avant Diagnostics, Inc (Filer) CIK: 0001451929 (see all company filings)

IRS No.: 980599151 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54004 | Film No.: 19677082
SIC: 8071 Services-Medical Laboratories